Nabla Bio has entered a new multi-year research collaboration with Takeda to advance AI-driven design of protein therapeutics ...

Where training sets were once scraped freely from the web or collected from low-paid annotators, companies are looking to ...

NOD2 deficiency is involved in the pathogenesis of Crohn’s disease (CD) due to failure of gut innate immunity and loss of ...

U.S. biotech firm Nabla Bio said on Tuesday it has signed a second major research partnership with Japanese drugmaker Takeda ...

Discover how the computational analysis of high-plex imaging can enhance spatial resolution and reproducibility to advance ...

ChatGPT’s mobile app may have reached its growth peak, according to new data from app intelligence firm Apptopia.

MindWalk Holdings Corp. reported record sales, improved margins, and a strengthened balance sheet post-divestiture. Learn more about HYFT stock here.

An update from Collplant Holdings ( ($CLGN) ) is now available. On October 16, 2025, CollPlant Biotechnologies announced the development of a ...

Nabla Bio partners with Takeda to use its AI platform JAM for designing antibodies, receiving upfront payments and potential ...

A panel of senior mortgage executives at The Sales Mastery event talked about how leaders should be adding value in this ...

New business model reflects strategic transition to a global biotech platform focused on business development and translational clinical ...

CellCodex has been established by an experienced team with a mission to provide better biological data to train advanced ...